CRISPR技術の市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

CRISPR技術市場規模は2023年に35億米ドルと評価され、2024年の40億8,000万米ドルから2032年には138億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは16.5%で成長する見通しです。

CRISPR技術、すなわちClustered Regularly Interspaced Short Palindromic Repeatsは、あらゆるDNA配列に正確な修正を加えることを可能にし、遺伝子編集に革命をもたらしました。この機能により、遺伝的欠陥の修正、病気の除去、作物の収穫品質の向上が可能になります。合成ガイドRNAとCas9ヌクレアーゼを利用することで、研究者は正確な切断による標的ゲノム改変を行うことができ、遺伝子編集手法を効果的に変革することができます。世界のCRISPR市場は、微生物学的応用の増加、ゲノム研究に対する官民の実質的な投資によって大きく牽引されています。さらに、遺伝性疾患の蔓延が、特に作物改良におけるCRISPRアプリケーションの需要を高めています。しかし、倫理的な問題やCRISPR技術の限られた専門知識は、当面の市場成長に影響を与える可能性のある課題を提起しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析

CRISPR技術市場規模：製品とサービス別& CAGR（2025-2032）

• 市場概要
• 製品
  • CRISPRキットと酵素
  • CRISPRライブラリ
  • その他の製品
  • デザインツール
  • 抗体
  • その他の試薬
• サービス
  • GRNA設計とベクター構築
  • 細胞株工学
  • スクリーニングサービス
  • その他のサービス
  • エピゲノム編集
  • 転写活性化

CRISPR技術市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 医薬品の発見と開発
• 農業
• その他の用途
  • バイオ燃料
  • 獣医

CRISPR技術市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 製薬・バイオテクノロジー企業
• 学術調査機関
• その他
  • CRO
  • CDMOs

CRISPR技術市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• CRISPR Therapeutics（Switzerland/USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Beam Therapeutics（USA）
• Mammoth Biosciences（USA）
• Caribou Biosciences（USA）
• Synthego（USA）
• ERS Genomics（Ireland）
• Takara Bio（Japan）
• Merck KGaA（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（Integrated DNA Technologies（IDT））（USA）
• Horizon Discovery（PerkinElmer Inc.）（UK/USA）
• GenScript（USA）
• Agilent Technologies（USA）
• New England Biolabs（USA）
• Cellectis（France）
• Sangamo Therapeutics（USA）
• Addgene（USA）
• Biocytogen Co., Ltd.（China）

結論と提言

CRISPR Technology Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 4.08 billion in 2024 to USD 13.84 billion by 2032, growing at a CAGR of 16.5% during the forecast period (2025-2032).

CRISPR technology, or Clustered Regularly Interspaced Short Palindromic Repeats, has revolutionized genetic editing by allowing precise modifications to any DNA sequence. This capability enables the correction of genetic defects, disease elimination, and enhancement of crop yield quality. By utilizing synthetic guide RNA and Cas9 nuclease, researchers can create targeted genome alterations through precise cuts, effectively transforming genetic editing methodologies. The global CRISPR market is significantly driven by increased microbiological applications and substantial public and private investments in genome research. Additionally, the prevalence of genetic diseases heightens the demand for CRISPR applications, particularly in crop improvement. However, ethical issues and limited expertise in CRISPR technology pose challenges that may impact market growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

CRISPR Technology Market Segments Analysis

Global CRISPR Technology Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Products and Services. Based on Application, the market is segmented into Drug discovery & development, Agriculture and Other applications. Based on End User, the market is segmented into Pharmaceutical & biotechnology companies, Academic & research institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the CRISPR Technology Market

Several factors are driving the growth of the CRISPR technology market, particularly in developed regions like North America and Europe, where increased funding for genetic research is prevalent. Significant investments from government agencies in the United States are enhancing advancements in materials, equipment, and methodologies related to genetic research. This financial support plays a crucial role in fostering medical breakthroughs, particularly for rare genetic diseases. Furthermore, European markets are reaping the benefits of genomic research funding initiatives, such as those provided by the National Human Genome Research Institute, further promoting innovation and progress within the CRISPR industry.

Restraints in the CRISPR Technology Market

The CRISPR Technology market faces significant restraints primarily due to the high costs associated with CRISPR-based therapies. Developing and manufacturing innovative genome editing solutions requires substantial investment of time and resources. Although the potential applications of CRISPR gene detection and diagnostic assay kits, as well as therapeutic treatments, are extensive, these expenses ultimately fall upon patients, limiting accessibility. The financial burden can hinder the widespread adoption of CRISPR technologies, posing challenges for both patients seeking treatment and providers aiming to develop effective, affordable genome editing tools. This economic barrier is a critical concern affecting the growth of the market.

Market Trends of the CRISPR Technology Market

The CRISPR technology market is witnessing a significant trend towards the integration of artificial intelligence (AI) and machine learning (ML), enhancing the efficiency and precision of gene editing processes. This synergy allows for superior target identification and off-target prediction, significantly streamlining research in drug discovery and diagnostics. As AI and ML tools enable rapid analysis of vast datasets, they facilitate the identification of therapeutic targets, leading to more effective treatments and innovations in genetic research. Consequently, the convergence of these technologies is propelling the CRISPR market forward, aligning with a broader shift towards automation and intelligence in biotechnological advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global CRISPR Technology Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Products
  • CRISPR kits & Enzymes
  • CRISPR Libraries
  • Other Products
  • Design Tools
  • Antibodies
  • Other Reagents
• Services
  • GRNA Design & Vector Construction
  • Cell Line Engineering
  • Screening Services
  • Other Services
  • Epigenome Editing
  • Transcriptional Activation

Global CRISPR Technology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug discovery & development
• Agriculture
• Other applications
  • Biofuels
  • Veterinary

Global CRISPR Technology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & biotechnology companies
• Academic & research institutes
• Others
  • CROs
  • CDMOs

Global CRISPR Technology Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, End User)
  • US
  • Canada
• Europe (Product & Services, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CRISPR Therapeutics (Switzerland/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ERS Genomics (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Integrated DNA Technologies (IDT)) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (PerkinElmer Inc.) (UK/USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Addgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations